You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic purpura fulminans

Showing 26 - 50 of 2,976
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Jan 13, 2023

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Purpura, Thrombocytopenic, Idiopath Thrombocytopenic Purp, Aspirin Trial (Aspirin)

Not yet recruiting
  • Purpura, Thrombocytopenic
  • +2 more
  • (no location specified)
Mar 15, 2022

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
  • Brno, Czechia
  • +10 more
Apr 29, 2021

T Cells and Natural Killer Cells Expression in Immune

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • Laboratory investigations for control
  • Laboratory investigations for patients
  • (no location specified)
Oct 13, 2021

Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)

Recruiting
  • Crohn Disease
  • +26 more
  • Fecal Microbiota Transplantation
  • Hong Kong, Shatin, Hong Kong
    The Chinese University of Hong Kong
Feb 10, 2022

Idiopathic Thrombocytopenic Purpura Trial in Worldwide (Romiplostim)

Completed
Has Results
  • Idiopathic Thrombocytopenic Purpura
  • Romiplostim
  • Anaheim, California
  • +47 more
Sep 8, 2022

Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • STSA-1301 subcutaneous injection
  • Placebo
  • Beijing, Chaoyang District, China
    Beijing Ditan Hospital,Capital Medical University
Nov 28, 2023

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)

Recruiting
  • Immune Thrombocytopenic Purpura
  • Valhalla, New York
    New York Medical College
Aug 4, 2021

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Idiopathic Thrombocytopenic Purpura (ITP) Trial in Taiwan (PG2)

Completed
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Changhua, Taiwan
  • +3 more
Mar 30, 2021

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting
  • Thrombocytopenia, Immune
  • Heparin Induced Thrombocytopenia
  • (no location specified)
Mar 24, 2023

Immune Thrombocytopenia Trial (Daratumumab Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Daratumumab Injection
  • (no location specified)
Sep 28, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 17, 2023

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Immune Thrombocytopenia Trial (Terbutaline, Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Aug 6, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • CM313 Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023